ÓÃÈËÌå×öʵÑ飬ŪÇåÐÂÒ©»òÖÎÁÆ·½·¨µÄ°²È«ÐԺ͹¦Ð§¡£Ò»°ã¶øÑÔ£¬ÁÙ´²ÊµÑé·ÖΪ3¸ö£¨ÓÐʱ4¸ö£©½×¶Î£ºµÚÒ»½×¶ÎÆÀ¹ÀÒ©ÎïµÄ°²È«ÐÔ£»µÚ¶þ½×¶Î¸ãÇåÒ©ÎïµÄ×î¼ÑҩЧºÍ¼ÁÁ¿£»µÚÈý½×¶Î£¨²¡ÈËÊýÁ¿×î¶àµÄ½×¶Î£©¸ãÇåÒ©ÎïµÄÁÙ´²Ò©Ð§¡£ÓÐʱ»¹ÓеÚËĽ׶Σ¬ÕâÆÚ¼äÒ©ÎïµÄ³¤ÆÚЧ¹ûÔÚ½ÓÊÜÒ©ÎïµÄ²¡ÈËÖб»¼à²â¡£ÁÙ´²ÊµÑéÊÇÐÂÒ©¿ª·¢¹ý³ÌÖкÄʱ×£¬·ÑÓÃ×î¸ßµÄ²¿·Ö£¬Ò»°ãÒª»¨·Ñ5ǧÍòµ½2ÒÚÃÀÔªºÍ3µ½5Äêʱ¼ä¡£
Studies performed on humans to determine the safety and efficacy of new drugs or therapies. Typically, clinical trials are divided into three (and sometimes four) phases: phase I trials evaluate the safety of the drug; phase II trials determine the optimum efficacy and dosage of the drug; and phase III trials (the largest phase in terms of number of patients) determine the clinical efficacy of the drug. Sometimes a phase IV (post-approval) trial is also pursued, where the long-term effects of the drug are monitored on those receiving prescriptions. Clinical trials are the longest and most expensive part of the process of creating a new drug, typically costing $50-200 million and taking 3-5 years.